Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin US00287Y1091
Ticker ABBV
Company ABBVIE
Currency $
Price
Aware Investor Index (AII) 92.1729
Recommendation STRONG BUY
P/E 80.50
ROE 100.00 %
Capitalization 328,316,720,000 $
Dividend Yield 1.05 %
P/S 14.36
AII Position 41
P/E Position 707
ROE Position 29
Capitalization Position 11
Dividend Yield Position 510
Sales 22,859,000,000 $
10-Year Average Earnings 4,078,250,000 $
Shares Outstanding 1,637,000,000
Equity 3,945,000,000 $
Dividend per Share 2.1 $
Industry Pharmaceutical
Country United States
ABBVIE Investor Relations Web Site http://www.abbvieinvestor.com







Sales:

YEAR MONTH AMOUNT
2015 12 22,859,000,000.00 $
2014 12 19,960,000,000.00 $
2013 12 18,790,000,000.00 $
2012 12 18,380,000,000.00 $
2011 12 17,444,000,000.00 $
2010 12 15,638,000,000.00 $
2009 12 14,214,000,000.00 $
2008 12 14,179,000,000.00 $

Earnings:

YEAR MONTH AMOUNT
2015 12 5,144,000,000.00 $
2014 12 1,774,000,000.00 $
2013 12 4,128,000,000.00 $
2012 12 5,275,000,000.00 $
2011 12 3,433,000,000.00 $
2010 12 4,178,000,000.00 $
2009 12 4,636,000,000.00 $
2008 12 4,058,000,000.00 $

Equity:

YEAR MONTH AMOUNT
2015 12 3,945,000,000.00 $
2014 12 1,742,000,000.00 $
2013 12 4,492,000,000.00 $
2012 12 3,363,000,000.00 $

Shares Outstanding:

YEAR MONTH AMOUNT
2015 12 1,637,000,000
2014 12 1,610,000,000
2013 12 1,604,000,000
2012 12 1,577,000,000

 












Bloomberg News for ABBVIE:

Mar 21, 2017
Goldman Says These Dividend Stocks Will Do Well Even With the Fed Hiking Rates
WHR, HD, LOW, PHM, MO, RAI, ADM, CVS, MJN, VLO, PSX, MPC, TSO, LM, HBAN, KEY, MMC, MS, BEN, UNM, ABBV, PFE, AMGN, CAH, MDT, ABT, DGX, BA, NLSN, ITW, HON, IR, CSCO, XRX, HPQ, IBM, TXN, MSI, MSFT, GLW...
Jun 12, 2013
EPS in the First Quarter of ’13 for S&P 500 Stocks by Industry
8.6 Mar 4/23 AMGN Amgen Inc 1.96 1.61 21.7 1.84 6.5 Mar 4/26 ABBV AbbVie Inc. 0.68 0.56 21.4 0.67 1.5 Mar 5/2 ACT Actavis Inc ...
Jun 12, 2013
EPS in the First Quarter of ’13 for S&P 500 Stocks by Sectors
4.8 Mar 4/23 AMGN Amgen Inc 1.96 1.61 21.7 1.84 6.5 Mar 4/26 ABBV AbbVie Inc. 0.68 0.56 21.4 0.67 1.5 Mar 5/2 ACT Actavis Inc ...
Jun 12, 2013
Positive EPS Surprises for First Quarter of ’13 for S&P 500
62 1.6 Mar 4/30 EQR Equity Residential 0.64 0.61 4.9 0.63 1.6 Mar 4/26 ABBV AbbVie Inc. 0.68 0.56 21.4 0.67 1.5 Mar 4/25 CELG Celgene Corp ...
May 16, 2013
And the Winner of the Top Student-Run Investment Fund Is ...
Apache (APA), -15.42 percent UnitedHealth Group (UNH), -2.52 percent AbbVie (ABBV), -2.39 percent FIXED INCOME First Place: Stetson University...
Dec 10, 2012
Abbott Spinoff AbbVie Begins Trading to Determine Value
percent to $30.30 at 4 p.m. New York time. AbbVie when-issued shares, trading under the ticker ABBV-W, opened at $37 and fell 5.4 percent to $35. The secondary market for the when-issued shares...
Feb 14, 2013
SAC Capital Advisors Holdings in 4th Quarter: 13F Alert
Alcatel-Lucent-Sponsored ADR ALU US 54,244,194 39,024,600 39,024,600 AbbVie Inc ABBV US 51,877,221 1,518,654 1,518,654 Analog Devices Inc ADI US 47,426...
Nov 14, 2014
Maverick Capital Ltd Holdings in 3rd Quarter: 13F Alert
Plc-Series C LBTYK US 279,296,113 6,809,609 238,560 AbbVie Inc ABBV US 272,833,865 4,723,578 1,488,445 CBS Corp-Class B Non Voting CBS US 258,296...
May 3, 2013
S&P 500 Stocks Biggest Weekly Changes in Target Price
44.58 42.09 3.526 THC TENET HEALTHCAR 5.90 14 49.18 46.44 4.043 ABBV ABBVIE INC 5.85 6 46.22 43.67 3.800 TWX TIME WARNER INC 5...
Jun 12, 2013
Higher, Lower, Unchanged and Reversed EPS for S&P 500
6.7 Mar 4/23 AMGN Amgen Inc 1.96 1.61 21.7 1.84 6.5 Mar 4/26 ABBV AbbVie Inc. 0.68 0.56 21.4 0.67 1.5 Mar 4/18 AN AutoNation Inc ...


Google News for ABBVIE:

Economic News - 5 hours ago
Going Through the Chart for AbbVie Inc. (ABBV)
After staying quite for a long time AbbVie Inc. (NYSE:ABBV) shares have recently been behaving interestingly to keep investors awake. Analysts often use price and volume data to predict future stock performance. In the case of ABBV, the chart has some interesting things to say about where the stock might ...
Frisco Fastball
AbbVie a Top Socially Responsible Dividend Stock With 3.0% Yield ...
AbbVie Inc (Symbol: ABBV) has been named a Top Socially Responsible Dividend Stock by Dividend Channel , signifying a stock with above-average ''DividendRank'' statistics including a strong 3.0% yield, as well as being recognized by prominent asset managers as being a socially responsible ...
StockNewsJournal
Better Buy: Pfizer (PFE) vs. AbbVie (ABBV)
AbbVie's (NYSE:ABBV) performance, on the other hand, warrants plenty of jumping. The stock is up more than 50% and is on track for its best yearly gain ever. All that's water under the bridge, though. What really matters for investors is how stocks will perform in the future. Both Pfizer and AbbVie have solid ...
The Ledger Gazette
AbbVie (ABBV) a Strong Buy on Top-End Earnings Momentum
Portfolio Grader currently ranks AbbVie Inc (NYSE:ABBV) a Strong Buy. The methods for fundamental and quantitative metrics used in this analytical tool, developed by Louis Navellier evaluates and ranks nearly 5,000 stocks each week. ABBV has maintained this ranking for the last month. With a $153.1 ...
Nasdaq - 3 days ago
AbbVie (ABBV) Phase 3 Study of VENCLEXTA/ VENCLYXTO in ...
AbbVie (NYSE: ABBV), a research and development based global biopharmaceutical company, today announced the first presentation of efficacy and safety results from MURANO, an international, multicenter, open-label, randomized Phase 3 study of VENCLEXTA™/VENCLYXTO™ (venetoclax) in ...
StreetInsider.com
AbbVie (NYSE:ABBV) Given a $84.00 Price Target at BMO Capital ...
AbbVie logo AbbVie (NYSE:ABBV) has been given a $84.00 price objective by investment analysts at BMO Capital Markets in a research report issued on Monday, December 4th. The firm currently has a “hold” rating on the stock. BMO Capital Markets' price target indicates a potential downside of 13.80% ...
Motley Fool
Advice by Analysts to Buy Healthcare Stock: AbbVie Inc. (ABBV)
AbbVie Inc. (ABBV) stock price traded with surging change along with the volume 11.56 million shares on Friday trading session. Shares are trading price at $97.45 with move of 1.19%. The company's 3-months average volume stands at 6.1 million. When we divide the last trade volume by the 3-month ...
StockNewsGazette
AbbVie Raises Dividend 11%... What Now?
AbbVie has a very strong pipeline, and I expect continues double-digit earnings growth for the rest of the decade. Despite a runup in share price, ... I've been a big fan of pharmaceutical company AbbVie (ABBV) ever since it spun off from Abbott Labs (ABT) back in 2012. I'm proud to say I began my ...
Motley Fool - 10 Dec 2017
Alps Advisors Has Decreased Abbvie (ABBV) Stake By $3.03 Million ...
Alps Advisors Inc decreased Abbvie Inc (ABBV) stake by 5.79% reported in 2017Q2 SEC filing. Alps Advisors Inc sold 42,094 shares as Abbvie Inc (ABBV)'s stock rose 6.17%. The Alps Advisors Inc holds 684,793 shares with $49.65M value, down from 726,887 last quarter. Abbvie Inc now has $155.57B ...
The Ledger Gazette
Wendell David Associates Has Cut Its Abbvie (ABBV) Holding as ...
Wendell David Associates Inc decreased its stake in Abbvie (ABBV) by 7.09% based on its latest 2017Q2 regulatory filing with the SEC. Wendell David Associates Inc sold 9,157 shares as the company's stock rose 6.17% with the market. The institutional investor held 119,910 shares of the major ...


Back